RRM2B Gene

Name ribonucleotide reductase M2 B (TP53 inducible)
Description This gene encodes the small subunit of a p53-inducible ribonucleotide reductase. This heterotetrameric enzyme catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates. The product of this reaction is necessary for DNA synthesis. Mutations in this gene have been associated with autosomal recessive mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia-5, and mitochondrial neurogastrointestinal encephalopathy. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRRM2B encodes the p53‐inducible small subunit of ribonucleotide reductase (p53R2), a protein that is fundamental to deoxyribonucleotide triphosphate (dNTP) production for both nuclear DNA repair and mitochondrial DNA (mtDNA) synthesis. Mutations in RRM2B have been shown to cause severe mtDNA depletion syndromes and related disorders, as evidenced by cases of profound muscle mtDNA loss and early‐onset mitochondrial dysfunction. In quiescent or postmitotic cells, where the traditional S‐phase subunit R2 is absent, p53R2 is indispensable for maintaining mtDNA and enabling efficient repair of damaged nuclear DNA. Dysfunctional p53R2, whether by missense, nonsense, or splice‐site mutations, disrupts this dNTP supply, thereby impairing both mtDNA replication and genomic integrity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in nucleotide synthesis, RRM2B is tightly regulated in response to DNA damage and stress through both p53‐dependent and p53‐independent mechanisms. In numerous studies, altered expression of p53R2 has been linked to changes in cell cycle regulation, apoptotic sensitivity, and epithelial–mesenchymal transition in various cancers, including lung, cervical, head and neck, and prostate carcinomas. Its involvement in key signaling cascades—such as those mediated by Akt, MEK, or even transcription factors like E2F1 and FOXO3—underscores its dual capacity as both a guardian of genomic stability and a modulator of tumor progression. Changes in p53R2 levels have been shown to influence sensitivity to radiochemotherapy and genotoxic agents, making its expression a promising prognostic biomarker in oncology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence has further illuminated the complex regulation and multifunctional nature of RRM2B. Detailed structural and biochemical studies have revealed differences between p53R2 and the canonical R2 subunit, explaining distinct aspects of iron coordination, radical generation, and binding affinity to the R1 catalytic subunit. In addition, p53R2 exerts nontraditional roles by directly interacting with metabolic enzymes such as mitochondrial thioredoxin reductase (TrxR2) and pyrroline‐5‐carboxylate reductases, thereby contributing to reactive oxygen species (ROS) scavenging and mitochondrial homeostasis. Furthermore, its expression can be modulated through alternative pathways—including p53-independent routes mediated by factors like E2F1—which may ultimately impact apoptotic thresholds and the cellular response to genotoxic as well as mechanical stress. Collectively, these insights underscore the pivotal role of RRM2B in safeguarding both nuclear and mitochondrial genomes and suggest that targeting its regulatory networks could provide novel therapeutic opportunities."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "37", "end_ref": "49"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alice Bourdon, Limor Minai, Valérie Serre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng2040"}], "href": "https://doi.org/10.1038/ng2040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17486094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17486094"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "T Yamaguchi, K Matsuda, Y Sagiya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2001)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11719458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11719458"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lijun Xue, Bingsen Zhou, Xiyong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12615712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12615712"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Giovanna Pontarin, Paola Ferraro, Leonardo Bee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1211289109"}], "href": "https://doi.org/10.1073/pnas.1211289109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22847445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22847445"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Henna Tyynismaa, Emil Ylikallio, Mehul Patel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2009.07.009"}], "href": "https://doi.org/10.1016/j.ajhg.2009.07.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19664747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19664747"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Belén Bornstein, Estela Area, Kevin M Flanigan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2008.04.006"}], "href": "https://doi.org/10.1016/j.nmd.2008.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18504129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18504129"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Gittan Kollberg, Niklas Darin, Karin Benan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2008.11.014"}], "href": "https://doi.org/10.1016/j.nmd.2008.11.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19138848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19138848"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Giovanna Pontarin, Paola Ferraro, Chiara Rampazzo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.202283"}], "href": "https://doi.org/10.1074/jbc.M110.202283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21297166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21297166"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nandaki Keshavan, Jose Abdenur, Glenn Anderson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The natural history of infantile mitochondrial DNA depletion syndrome due to RRM2B deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41436-019-0613-z"}], "href": "https://doi.org/10.1038/s41436-019-0613-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31462754"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31462754"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Brent A Penque, Leila Su, Jianghai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A homozygous variant in RRM2B is associated with severe metabolic acidosis and early neonatal death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejmg.2018.11.008"}], "href": "https://doi.org/10.1016/j.ejmg.2018.11.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30439532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30439532"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Robert D S Pitceathly, Elisa Fassone, Jan-Willem Taanman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kearns-Sayre syndrome caused by defective R1/p53R2 assembly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2010.088328"}], "href": "https://doi.org/10.1136/jmg.2010.088328"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21378381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21378381"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "R de las Peñas, M Sanchez-Ronco, V Alberola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdj135"}], "href": "https://doi.org/10.1093/annonc/mdj135"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16407418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16407418"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Young Kwang Chae, Jonathan F Anker, Benedito A Carneiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic landscape of DNA repair genes in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8196"}], "href": "https://doi.org/10.18632/oncotarget.8196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27004405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27004405"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Bingsen Zhou, Xiyong Liu, Xueli Mo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14583450"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14583450"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mei-Ling Kuo, Mabel Bin-Er Lee, Michelle Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep18846"}], "href": "https://doi.org/10.1038/srep18846"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26733354"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26733354"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Iosifina P Foskolou, Christian Jorgensen, Katarzyna B Leszczynska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2017.03.005"}], "href": "https://doi.org/10.1016/j.molcel.2017.03.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28416140"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28416140"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hua Tian, Chao Ge, Hong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.26929"}], "href": "https://doi.org/10.1002/hep.26929"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24214128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24214128"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hiroshi Okumura, Shoji Natsugoe, Naoya Yokomakura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-05-2416"}], "href": "https://doi.org/10.1158/1078-0432.CCR-05-2416"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16778101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16778101"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Keqiang Zhang, Jun Wu, Xiwei Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-10-0728"}], "href": "https://doi.org/10.1158/1535-7163.MCT-10-0728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21216934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21216934"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hong-Lin Devlin, Phillip C Mack, Rebekah A Burich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-07-2027"}], "href": "https://doi.org/10.1158/1541-7786.MCR-07-2027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18505925"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18505925"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xin Wang, Anna Zhenchuk, Klas G Wiman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of p53R2 and its role as potential target for cancer therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2008.07.019"}], "href": "https://doi.org/10.1016/j.canlet.2008.07.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18760875"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18760875"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Peter Smith, Bingsen Zhou, Nam Ho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi9001425"}], "href": "https://doi.org/10.1021/bi9001425"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19728742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19728742"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jun Sato, Takashi Kimura, Takuro Saito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatobiliary Pancreat Sci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00534-011-0376-7"}], "href": "https://doi.org/10.1007/s00534-011-0376-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21451941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21451941"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Er-Chieh Cho, Mei-Ling Kuo, Xiyong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2044"}], "href": "https://doi.org/10.18632/oncotarget.2044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24947616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24947616"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Souichi Yanamoto, Goro Kawasaki, Izumi Yoshitomi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0304-3835(02)00588-8"}], "href": "https://doi.org/10.1016/s0304-3835(02"}, {"type": "t", "text": "00588-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12565178"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12565178"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Mei-Ling Kuo, Alexander J Sy, Lijun Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by p53 during senescence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep00822"}], "href": "https://doi.org/10.1038/srep00822"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23139867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23139867"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Nan-Yung Hsu, Jeng-Yuan Wu, Xiyong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anticancer Res (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21965764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21965764"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "K Kawakita, T Nishiyama, T Fujishiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Akt phosphorylation in human chondrocytes is regulated by p53R2 in response to mechanical stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Osteoarthritis Cartilage (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.joca.2012.08.022"}], "href": "https://doi.org/10.1016/j.joca.2012.08.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22954457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22954457"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Claudia Rodríguez-López, Luis M García-Cárdaba, Alberto Blázquez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmedgenet-2019-106649"}], "href": "https://doi.org/10.1136/jmedgenet-2019-106649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32161153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32161153"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Katsutoshi Ohno, Yukimasa Tanaka-Azuma, Yukio Yoneda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mutat Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mrgentox.2005.09.002"}], "href": "https://doi.org/10.1016/j.mrgentox.2005.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16236544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16236544"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Weihua Qiu, Bingsen Zhou, Dana Darwish, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2005.12.019"}], "href": "https://doi.org/10.1016/j.bbrc.2005.12.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16376858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16376858"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Chao Jiang, Rui Xu, Xiao-Xing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2017.1320629"}], "href": "https://doi.org/10.1080/15384101.2017.1320629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28841361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28841361"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Xiyong Liu, Lijun Xue, Yun Yen "}, {"type": "b", "children": [{"type": "t", "text": "Redox property of ribonucleotide reductase small subunit M2 and p53R2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Methods Mol Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-1-60327-517-0_15"}], "href": "https://doi.org/10.1007/978-1-60327-517-0_15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19082948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19082948"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Naoya Yokomakura, Shoji Natsugoe, Hiroshi Okumura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17671702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17671702"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Shigeto Matsushita, Ryuji Ikeda, Tomoko Fukushige, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dermatol Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdermsci.2012.07.005"}], "href": "https://doi.org/10.1016/j.jdermsci.2012.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22902076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22902076"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Charles A Kunos, Kathryn Winter, Adam P Dicker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/IGC.0b013e31828b4eb5"}], "href": "https://doi.org/10.1097/IGC.0b013e31828b4eb5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23552804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23552804"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Aziz Shaibani, Oleg A Shchelochkov, Shulin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/archneurol.2009.139"}], "href": "https://doi.org/10.1001/archneurol.2009.139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19667227"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19667227"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Jiewei Chen, Shuman Li, Yongbo Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3858-4"}], "href": "https://doi.org/10.1186/s12885-017-3858-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29237424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29237424"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Charlotte L T Jørgensen, Bent Ejlertsen, Karsten D Bjerre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-13-541"}], "href": "https://doi.org/10.1186/1471-2407-13-541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24215511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24215511"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Jun-Juan Qi, Ling Liu, Ji-Xiang Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E2F1 regulates p53R2 gene expression in p53-deficient cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-014-2244-7"}], "href": "https://doi.org/10.1007/s11010-014-2244-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25312903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25312903"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Chunmei Piao, Cha-Kyung Youn, Min Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.21591"}], "href": "https://doi.org/10.4161/cc.21591"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22895183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22895183"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Josef Finsterer, Sinda Zarrouk-Mahjoub "}, {"type": "b", "children": [{"type": "t", "text": "Phenotypic and Genotypic Heterogeneity of RRM2B Variants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropediatrics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/s-0037-1609039"}], "href": "https://doi.org/10.1055/s-0037-1609039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29241262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29241262"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Seon-Joo Park, Hong Beum Kim, Chunmei Piao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53R2 regulates thioredoxin reductase activity through interaction with TrxR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.11.099"}], "href": "https://doi.org/10.1016/j.bbrc.2016.11.099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27866984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27866984"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Ali Tebbi, Olivier Guittet, Karine Tuphile, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.649640"}], "href": "https://doi.org/10.1074/jbc.M115.649640"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25878246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25878246"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Bingsen Zhou, Leila Su, Yate-Ching Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-10-0023"}], "href": "https://doi.org/10.1158/1535-7163.MCT-10-0023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20484015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20484015"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "David Lembo, Manuela Donalisio, Maura Cornaglia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virus Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.virusres.2006.06.011"}], "href": "https://doi.org/10.1016/j.virusres.2006.06.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16872707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16872707"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "Katarzyna Iwanicka-Pronicka, Elżbieta Ciara, Dorota Piekutowska-Abramczuk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital cochlear deafness in mitochondrial diseases related to RRM2B and SERAC1 gene defects. A study of the mitochondrial patients of the CMHI hospital in Warsaw, Poland."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Pediatr Otorhinolaryngol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijporl.2019.03.015"}], "href": "https://doi.org/10.1016/j.ijporl.2019.03.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30909120"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30909120"}]}, {"type": "r", "ref": 48, "children": [{"type": "t", "text": "Xiaochen Wang, Xiyong Liu, Lijun Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.05.114"}], "href": "https://doi.org/10.1016/j.bbrc.2011.05.114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21640705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21640705"}]}, {"type": "r", "ref": 49, "children": [{"type": "t", "text": "Olivier Guittet, Ali Tebbi, Marie-Hélène Cottet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nitric Oxide (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.niox.2008.04.011"}], "href": "https://doi.org/10.1016/j.niox.2008.04.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18474260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18474260"}]}]}]}
Synonyms MTDPS8A, P53R2, MTDPS8B
Proteins RIR2B_HUMAN
NCBI Gene ID 50484
API
Download Associations
Predicted Functions View RRM2B's ARCHS4 Predicted Functions.
Co-expressed Genes View RRM2B's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View RRM2B's ARCHS4 Predicted Functions.

Functional Associations

RRM2B has 6,855 functional associations with biological entities spanning 9 categories (molecular profile, organism, disease, phenotype or trait, functional term, phrase or reference, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 123 datasets.

Click the + buttons to view associations for RRM2B from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RRM2B gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of RRM2B gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RRM2B gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RRM2B gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RRM2B gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of RRM2B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of RRM2B gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with RRM2B protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with RRM2B gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RRM2B gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of RRM2B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of RRM2B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with RRM2B gene from the curated ClinVar Gene-Phenotype Associations dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing RRM2B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing RRM2B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing RRM2B protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing RRM2B protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with RRM2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with RRM2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of RRM2B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with RRM2B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with RRM2B gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with RRM2B gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of RRM2B protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by RRM2B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving RRM2B gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving RRM2B gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with RRM2B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with RRM2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with RRM2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with RRM2B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with RRM2B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for RRM2B protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RRM2B gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RRM2B gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of RRM2B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing RRM2B from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with RRM2B gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with RRM2B gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with RRM2B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing RRM2B from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of RRM2B gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving RRM2B gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving RRM2B gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving RRM2B gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing RRM2B protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by RRM2B gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by RRM2B gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by RRM2B gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of RRM2B gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of RRM2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of RRM2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of RRM2B gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for RRM2B protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of RRM2B gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of RRM2B gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of RRM2B protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPM Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of RRM2B protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with RRM2B gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for RRM2B from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with RRM2B gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
HumanCyc Pathways pathways involving RRM2B protein from the HumanCyc Pathways dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for RRM2B protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of RRM2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate RRM2B protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways pathways involving RRM2B protein from the KEGG Pathways dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate RRM2B protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of RRM2B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of RRM2B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with RRM2B gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of RRM2B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LOCATE Curated Protein Localization Annotations cellular components containing RRM2B protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain RRM2B protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by RRM2B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting RRM2B gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of RRM2B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by RRM2B gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of RRM2B gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
MW Enzyme Metabolite Associations interacting metabolites for RRM2B protein from the MW Gene Metabolite Associations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of RRM2B gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing RRM2B protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with RRM2B gene from the curated OMIM Gene-Disease Associations dataset.
PANTHER Pathways pathways involving RRM2B protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for RRM2B from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RRM2B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of RRM2B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving RRM2B protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving RRM2B protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with RRM2B protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate RRM2B protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving RRM2B protein from the PID Pathways dataset.
ProteomicsDB Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of RRM2B protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset.
Reactome Pathways 2014 pathways involving RRM2B protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving RRM2B protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of RRM2B gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of RRM2B gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of RRM2B gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RRM2B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RRM2B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of RRM2B gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of RRM2B gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with RRM2B protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of RRM2B gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of RRM2B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of RRM2B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of RRM2B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of RRM2B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of RRM2B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of RRM2B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with RRM2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with RRM2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving RRM2B protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving RRM2B protein from the WikiPathways Pathways 2024 dataset.